Decide at what price you'd be comfortable buying and we'll help you stay ready.
CME pairs revenue linked to trading and market-data activity with substantial operating leverage and consistent free cash flow. Its modest capital-spending needs have supported regular dividends and share repurchases.
Trailing-year operating income has grown faster than revenue, while the latest quarter's operating margin edged below its year-earlier level. This points to continued operating leverage with some quarterly cost variation, rather than a clearly changed financial model.
Whether revenue growth continues to outpace operating-expense growth and supports the recent trailing-year margin expansion.
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 3.6B | 3.6B | 4.3B | 5.5B | 5.1B | 5B | 7.2B | 10.9B | 10.2B | 12B | |
| (1.4B) | (1.3B) | (1.7B) | (2.3B) | (2.2B) | (2B) | (2B) | (2.1B) | (2.2B) | (2.3B) | |
| (921m) | (929.4m) | (1.1B) | (1.5B) | (1.6B) | (1.5B) | (1.5B) | (1.6B) | (1.6B) | (1.8B) | |
| (225.3m) | (208.5m) | (248.7m) | (473.3m) | (464.4m) | (385.4m) | (362.6m) | (352.6m) | (336.8m) | (330.9m) | |
| (248.4m) | (196.2m) | (327m) | (281.9m) | (223.8m) | (177m) | (184.5m) | (220.6m) | (215.8m) | (209.5m) | |
| 2.2B | 2.3B | 2.6B | 3.2B | 2.8B | 3B | 5.2B | 8.7B | 8B | 9.7B | |
| 128.5m | 543.9m | 740.2m | (1.2m) | 24.4m | 78.9m | 138.4m | 137.5m | 190m | 198.3m | |
| 123.5m | 117m | 157.7m | 178m | 166.2m | 166.9m | 162.7m | 159.4m | 160.9m | 173.4m | |
| — | — | — | — | — | 400.7m | — | — | — | 323m | |
| — | — | — | — | — | 30.4m | — | — | — | — | |
| (41.4m) | (328.2m) | (570m) | (534.9m) | (122.4m) | (88.5m) | (1.9B) | (4.7B) | (3.7B) | (4.9B) | |
| 2.3B | 2.5B | 2.8B | 2.7B | 2.7B | 3.4B | 3.5B | 4.2B | 4.5B | 5.3B | |
| (753.5m) | 1.4B | (814.3m) | (573.8m) | (615.7m) | (736.7m) | (799.3m) | (927.4m) | (1B) | (1.3B) | |
| 1.5B | 4B | 2B | 2.1B | 2.1B | 2.6B | 2.7B | 3.2B | 3.5B | 4.1B | |
| 0 | 0 | (1.5m) | 700k | (1.2m) | 500k | 0 | 0 | — | — | |
| 1.5B | 4.1B | 2B | 2.1B | 2.1B | 2.6B | 2.7B | 3.2B | 3.5B | 4B | |
| 4.53 | 11.94 | 5.71 | 5.91 | 5.87 | 7.29 | 7.40 | 8.86 | 9.67 | 11.16 |
Alpha Spread
Preferences
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more